During the past decade, Plicní stredisko Teplice, s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Plicní stredisko Teplice, s.r.o." #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Plicní stredisko Teplice, s.r.o." are "Asthma" (1 trials), "Chronic Cough" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Refractory and/or Unexplained Chronic Cough" (1 trials). Many other conditions were trialed in "Plicní stredisko Teplice, s.r.o." in a lesser frequency.

Most popular intervention types in "Plicní stredisko Teplice, s.r.o." are "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BAY1817080" (1 trials), "Ensifentrine" (1 trials), "FeNO measurement" (1 trials) and "Placebo to S-600918" (1 trials). Other intervention names were less common.

The vast majority of trials in "Plicní stredisko Teplice, s.r.o." are 4 trials for "All" genders.

Currently, there are NaN active trials in "Plicní stredisko Teplice, s.r.o.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Plicní stredisko Teplice, s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Plicní stredisko Teplice, s.r.o., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".